​

Funding Round

Series A - Umoja Biopharma

Series A - Umoja Biopharma

Investment Firm

Overview

Umoja Biopharma is a biopharmaceutical company developing next-generation immunotherapies intended to combat cancer.

Announced Date

Nov 18, 2020

Funding Type

Series A

Highlights

Location

United States, North America

Social

Investor Lead

MPM Capital

MPM Capital

MPM Capital is a early_stage_venture and late_stage_venture and private_equity and seed firm.

Qiming Venture Partners USA

Qiming Venture Partners USA

Qiming Venture Partners USA is a early_stage_venture and post_ipo firm.

Participant Investors

3

Investor Name
Participant InvestorQiming Venture Partners USA
Participant InvestorDCVC Bio
Participant InvestorMPM Capital

Round Details and Background

Umoja Biopharma raised $53000000 on 2020-11-18 in Series A

Umoja Biopharma is a biopharmaceutical company developing next-generation immunotherapies intended to combat cancer.

Company Funding History

3

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Nov 18, 2020
Series A - Umoja Biopharma
3-53.0M
Nov 21, 2019
Seed Round - Umoja Biopharma
2-undefined
Jun 15, 2021
Series B - Umoja Biopharma
7-210.0M

Recent Activity

There is no recent news or activity for this profile.